DCB控股(08040.HK)擬發展納米光催化防污材料營銷業務
DCB控股(08040.HK)公布,集團擬探索於其裝修及翻新項目應用新材料的潛在商機,已物色一種納米光催化防污材料(Nano-AM),集團發現Nano-AM或許能用於房屋及公寓的各表面並用於磚塊、瓷磚等裝修及翻新項目所用的建築材料,因此對各表面有出色的消毒及保護效果。
集團指,已與第三方公司訂立協議備忘錄,以藉集團的現有客戶群體及營銷網絡發展應用Nano-AM的業務,並為進一步開發Nano-AM的各項應用提供平台。
集團將主要負責NanoAM各項應用的開發、銷售及營銷,而訂約方將負責營運事宜。集團預期將組建一支獨立團隊發展新業務活動,新業務活動將無需高額的投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.